Cardiex Ltd - Asset Resilience Ratio
Cardiex Ltd (CDX) has an Asset Resilience Ratio of 0.16% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Cardiex Ltd (CDX) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Cardiex Ltd's Asset Resilience Ratio has changed over time. See CDX total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Cardiex Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CDX stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$27.98K | 0.16% |
| Total Liquid Assets | AU$27.98K | 0.16% |
Asset Resilience Insights
- Limited Liquidity: Cardiex Ltd maintains only 0.16% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Cardiex Ltd Industry Peers by Asset Resilience Ratio
Compare Cardiex Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 9.40% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Ok Biotech Co Ltd
TW:4155 |
Medical Devices | 0.32% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Cardiex Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Cardiex Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 38.50% | AU$4.87 Million ≈ $3.45 Million |
AU$12.65 Million ≈ $8.95 Million |
-0.36pp |
| 2023-06-30 | 38.86% | AU$5.56 Million ≈ $3.93 Million |
AU$14.30 Million ≈ $10.12 Million |
+30.43pp |
| 2022-06-30 | 8.43% | AU$1.04 Million ≈ $738.22K |
AU$12.38 Million ≈ $8.76 Million |
-5.20pp |
| 2021-06-30 | 13.63% | AU$1.54 Million ≈ $1.09 Million |
AU$11.26 Million ≈ $7.97 Million |
+6.81pp |
| 2020-06-30 | 6.82% | AU$728.54K ≈ $515.49K |
AU$10.68 Million ≈ $7.55 Million |
+46.59pp |
| 2019-06-30 | -39.77% | AU$-5.25 Million ≈ $-3.72 Million |
AU$13.21 Million ≈ $9.35 Million |
-- |
| 2017-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$2.96 Million ≈ $2.09 Million |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$4.60 Million ≈ $3.26 Million |
-- |
| 2003-06-30 | 0.97% | AU$15.00K ≈ $10.61K |
AU$1.54 Million ≈ $1.09 Million |
+0.01pp |
| 2002-06-30 | 0.96% | AU$15.00K ≈ $10.61K |
AU$1.56 Million ≈ $1.10 Million |
-- |
About Cardiex Ltd
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffnes… Read more